Ocular Therapeutix, Inc. (OCUL) DCF Valuation

Ocular Therapeutix, Inc. (OCUL) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Ocular Therapeutix, Inc. (OCUL) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate the financial outlook of Ocular Therapeutix, Inc. (OCUL) like a professional! This (OCUL) DCF Calculator provides you with pre-filled financials and the flexibility to modify revenue growth, WACC, margins, and other crucial assumptions to align with your projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 4.2 17.4 43.5 51.5 58.4 92.3 145.8 230.3 363.8 574.6
Revenue Growth, % 0 311.71 150.08 18.32 13.49 57.95 57.95 57.95 57.95 57.95
EBITDA -77.7 -146.1 -75.6 -61.9 -66.4 -92.3 -145.8 -230.3 -363.8 -574.6
EBITDA, % -1839.15 -839.48 -173.74 -120.22 -113.64 -100 -100 -100 -100 -100
Depreciation 2.5 2.8 2.4 2.1 3.0 16.7 26.4 41.7 65.9 104.1
Depreciation, % 59.85 15.93 5.56 4.1 5.1 18.11 18.11 18.11 18.11 18.11
EBIT -80.3 -148.9 -78.0 -64.0 -69.4 -92.3 -145.8 -230.3 -363.8 -574.6
EBIT, % -1899.01 -855.42 -179.3 -124.32 -118.74 -100 -100 -100 -100 -100
Total Cash 54.4 228.1 164.2 102.3 195.8 92.3 145.8 230.3 363.8 574.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 2.5 12.3 21.1 21.3 26.2
Account Receivables, % 60.28 70.4 48.56 41.41 44.79
Inventories 1.0 1.2 1.3 2.0 2.3 7.4 11.7 18.5 29.2 46.1
Inventories, % 22.57 6.9 2.87 3.83 3.94 8.02 8.02 8.02 8.02 8.02
Accounts Payable 3.3 2.7 4.6 5.1 4.4 22.3 35.3 55.7 88.0 138.9
Accounts Payable, % 77.31 15.57 10.55 9.95 7.51 24.18 24.18 24.18 24.18 24.18
Capital Expenditure -2.2 -.8 -1.2 -3.7 -6.1 -14.4 -22.8 -36.0 -56.9 -89.8
Capital Expenditure, % -52.95 -4.83 -2.74 -7.21 -10.42 -15.63 -15.63 -15.63 -15.63 -15.63
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -83.6 -152.7 -128.7 -57.2 -69.4 -90.3 -142.7 -225.4 -356.0 -562.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -83.5 -161.3 -134.5 -59.1 -78.4 -98.0 -158.8 -250.9 -396.3 -625.9
WACC, % 10.71 10.71 10.71 10.56 10.71 10.68 10.68 10.68 10.68 10.68
PV UFCF
SUM PV UFCF -1,044.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -638
Terminal Value -7,354
Present Terminal Value -4,428
Enterprise Value -5,472
Net Debt -112
Equity Value -5,359
Diluted Shares Outstanding, MM 86
Equity Value Per Share -62.61

What You Will Get

  • Real OCUL Financial Data: Pre-filled with Ocular Therapeutix’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Ocular Therapeutix’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Customizable Financial Metrics: Adjust essential parameters such as revenue projections, gross margin %, and R&D expenditures.
  • Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other financial metrics with ease.
  • High-Precision Accuracy: Leverages Ocular Therapeutix's actual financial data for reliable valuation results.
  • Effortless Scenario Analysis: Evaluate various assumptions and analyze results without hassle.
  • Efficiency Booster: Avoid the complexities of constructing detailed valuation models from the ground up.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based OCUL DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically recalculates Ocular Therapeutix’s intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
  5. Analyze and Decide: Utilize the outcomes to inform your investment or financial strategy.

Why Choose This Calculator for Ocular Therapeutix, Inc. (OCUL)?

  • Designed for Industry Experts: A sophisticated tool utilized by healthcare analysts, investment managers, and researchers.
  • Comprehensive Data: Ocular Therapeutix’s historical and projected financials are preloaded for precision.
  • Versatile Scenario Analysis: Effortlessly model various forecasts and assumptions.
  • Clear and Concise Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly Interface: Step-by-step guidance simplifies the entire calculation process.

Who Should Use Ocular Therapeutix, Inc. (OCUL)?

  • Investors: Gain insights into innovative therapies and make informed investment choices.
  • Healthcare Analysts: Utilize comprehensive data to assess the company's market position and growth potential.
  • Consultants: Tailor presentations and reports for clients focusing on the ophthalmic pharmaceutical sector.
  • Biotech Enthusiasts: Enhance your knowledge of drug development processes and therapeutic innovations.
  • Educators and Students: Employ real-world case studies in academic settings related to biotechnology and pharmaceuticals.

What the Template Contains

  • Pre-Filled Data: Contains Ocular Therapeutix’s historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model with automated calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC using custom inputs.
  • Key Financial Ratios: Evaluate Ocular Therapeutix's profitability, efficiency, and leverage.
  • Customizable Inputs: Easily modify revenue growth, margins, and tax rates.
  • Clear Dashboard: Visuals and tables summarizing essential valuation results.

No products were found matching.